✦ LIBER ✦

Immunosuppressive therapy in persistent hypocomplementemic glomerulonephritis and in lupus nephritis

✍ Scribed by Clark D. West; Nancy H. Holland; Janice M. McConville; A. James McAdams

Book ID: 118533981
Publisher: Elsevier Science
Year: 1965
Tongue: English
Weight: 714 KB
Volume: 67
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(65)80214-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Immunosuppressive Agents on Pe

Effect of Immunosuppressive Agents on Persistent Glomerulonephritis in Childhood

✍ Noriaki Kasai 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Immunosuppressive therapy in lupus nephr

Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

✍ Frédéric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

IgG subclasses in patients with membrano

IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis

✍ Imai, Hirokazu; Hamai, Keiko; Komatsuda, Atsushi; Ohtani, Hiroshi; Miura, Akira 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 636 KB

Rituximab is effective in the treatment

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy

✍ R Martínez, A Muñoz, M L Velloso, S Rodríguez Montero… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 119 KB

Early response to immunosuppressive ther

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

✍ Frédéric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 monthly pulses and 2 quarterly pulses with escalating doses) or a low‐dose IV CYC regimen (6 pulses of 500 mg g

P79 Systematic review and meta-analysis

P79 Systematic review and meta-analysis of immunosuppressant therapy clinical trials in membranous lupus nephritis.

✍ Vikas Majithia; Joshua T Swan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 86 KB